Not hard to get a patent given the efforts to get through all clinical stages of testing, that’s why it’s not price sensitive. You would expect granting patents to be a given in this space. The success of the trials is what will be price sensitive
Not hard to get a patent given the efforts to get through all...
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $20.55M | |||
| Open | High | Low | Value | Volume |
| 2.5¢ | 2.5¢ | 2.4¢ | $14.09K | 586.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 465637 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 19000 | 1 |
View Market Depth
| Last trade - 15.04pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.4¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 2.4¢ | 2.4¢ | 2.4¢ | 69659 | ||
| Last updated 15.54pm 14/05/2024 ? | |||||
| CHM (ASX) Chart |